Israeli AI Healthcare Co Aidoc Secures Landmark AI Funding
Aidoc, a leading Israel-based AI healthcare company, closed a landmark funding round to advance its clinical-grade foundation model, CARE, which enhances physicians’ decision-making. This is a major milestone for one of Israel’s leading and most exciting AI companies in the healthcare space.
The company’s AI solutions currently serve over 45 million patients annually across 150+ health systems worldwide. The investment will accelerate CARE’s development and expand Aidoc’s impact in transforming clinical workflows.
The USD150 million round attracted participation from NVIDIA’s venture capital arm, General Catalyst, and major U.S. healthcare systems, alongside other global investors.
Arnon, Tadmor-Levy represented Square Peg Capital as the lead equity investor in Aidoc’s latest round, with the transaction led by Simon Weintraub and Josh Hauser, supported by Asaf Tenenbaum.
